Peptide therapy as an 'easier method': what the evidence shows

What did @callmeburty actually say?

The creator argued that injectable GHK-Cu peptide is unnecessary because a topical copper peptide serum does "the same thing" for acne scarring and skin texture. They showed before-and-after photos, credited a few months of daily topical use, and pushed a specific two-ounce product as the cost-effective option.

The core pitch: skip the needle, buy this serum, apply it every morning, wait a couple months. They acknowledged that injectable GHK is "definitely a concentrated form" but framed the topical version as a simpler route to the same result. They also flagged that copper content varies between products, which is actually a fair point buried inside an otherwise oversimplified sales pitch.

The video is clearly affiliate-coded. The product recommendation, the "drop it below" language, and the nudge toward the larger size all read as sponsored content disclosures that never quite happened.

Does the science back this up?

GHK-Cu has real research behind it, but most of that research does not involve topical consumer serums. The equivalency claim between topical and injectable forms is where the video goes off the rails.

GHK-Cu (glycyl-L-histidyl-L-lysine copper) is a naturally occurring tripeptide with documented effects on collagen synthesis, wound healing, and skin remodeling in cell and animal studies. Pickart and Margolina (2018, Cosmetics) summarized decades of in vitro and animal data showing GHK-Cu stimulates collagen, elastin, and glycosaminoglycan production. Human clinical trials are a different story. A double-blind study by Leyden et al. (2004, Journal of the American Academy of Dermatology) found modest improvements in fine lines with topical copper peptide formulations, but the effect sizes were limited and the concentration of penetrating peptide was not verified.

The fundamental problem is skin penetration. The stratum corneum is a barrier. A tripeptide like GHK has a molecular weight around 340 daltons, which is within the theoretical cutoff for skin absorption, but copper chelation changes the formulation dynamics. There is no peer-reviewed human data confirming that over-the-counter GHK-Cu serums deliver pharmacologically relevant concentrations to the dermis, which is where scar remodeling actually happens.

What did they get wrong (or right)?

They got a few things right and one thing importantly wrong. The important wrong: claiming topical GHK does "the same thing" as injectable GHK-Cu is not supported by evidence. Bioavailability is not equivalent. That framing is misleading regardless of how well-intentioned the creator is.

What they got right: copper content does matter. GHK without adequate copper coordination is not GHK-Cu, it is just a peptide. Third-party testing is also a legitimate concern in an unregulated supplement space. These are real consumer-protection points that most TikTok peptide content skips entirely.

The before-and-after photos are anecdote, not evidence. Skin changes over months can reflect product use, but also changes in diet, sleep, sun exposure, skincare routine, or simple photo lighting. Single-subject testimonials cannot isolate the variable. The creator presents their own face as proof without acknowledging any of this, which is a methodological problem even if the results are genuine.

• Correct: copper content and third-party testing matter
• Correct: topical GHK-Cu has some skin research behind it
• Misleading: topical and injectable forms produce equivalent outcomes
• Unverifiable: personal before-and-after as product proof

What should you actually know?

If you are interested in GHK-Cu for skin, topical application is a reasonable low-risk starting point, but you should go in with calibrated expectations, not TikTok-scale promises.

Injectable GHK-Cu sits in a different regulatory and bioavailability category entirely. It is used in compounded peptide protocols prescribed through licensed providers, and it bypasses the penetration problem entirely. Whether that level of intervention is appropriate depends on clinical context, not a TikTok comment section. Comparing the two and calling them equivalent is like comparing a topical antibiotic to an IV antibiotic because they contain the same active ingredient.

For topical products specifically, look for formulations that list the GHK-Cu concentration explicitly, have third-party certificates of analysis available, and are manufactured in an FDA-registered facility. The creator's point about product variability is legitimate. Many GHK serums are underdosed or poorly stabilized.

What you should not do is treat this video as a clinical recommendation. No single creator's face, however improved, is a substitute for understanding what a product can realistically deliver at the tissue level.